Skip to main content
. 2018 Oct 25;5(2):e000848. doi: 10.1136/openhrt-2018-000848

Table 2A.

Clinical characteristics and presenting symptoms according to diagnoses (GOLD criteria)

COPD+
Ischaemia− (n=122)
COPD−
Ischaemia+ (n=43)
COPD+
Ischaemia+
(n=12)
Other spirometry finding
Ischaemia−
(n=20)
Normal findings (n=203) P values
Age, years 69.5 (8.9) 64.7 (7.5) 72.3 (6.2) 64.4 (11.9) 64.4 (11.4) 0.001*
Sex, % women 50.0 22.7 9.1 40.0 48.6 0.002
Ever smoker, % 71.7 76.7 91.7 60.0 56.9 0.006
Current smoker, % 15.0 14.0 25.0 10.0 8.9 0.282
History of CAD, % 33.6 51.2 83.3 55.0 25.7 <0.001
Chest discomfort, % 71.3 72.1 83.3 60.0 73.4 0.659
Dyspnoea, % 18.9 14.0 8.3 5.0 19.7 0.404
FEV1, % of predicted 83.1 (14.9) 97.8 (14.7) 73.7 (15.5) 81.3 (12.1) 99.0 (13.1) <0.001
VC, % of predicted 97.0 (15.1) 92.7 (11.6) 84.5 (11.1) 75.4 (8.9) 95.4 (12.0) <0.001*
BMI, kg/m2 29.1 (4.7) 30.0 (4.7) 27.4 (3.3) 30.4 (5.3) 27.6 (4.4) 0.001
Dyslipidaemia, % 38.5 51.2 58.3 45.0 33.5 0.115
SBP, mm Hg 140.0 (16.7) 141.3 (17.8) 141.7 (16.4) 141.3 (15.0) 137.2 (18.0) 0.421
DBP, mm Hg 80.3 (8.4) 81.0 (8.0) 77.5 (8.4) 81.8 (11.9) 79.5 (9.4) 0.573
Heart rate, bpm 70.8 (12.1) 70.5 (10.8) 72.8 (13.2) 70.0 (13.3) 68.1 (11.3) 0.214

P values are reported for ANOVA test for continuous variables and χ2 for dichotomous variables, unless otherwise specified.

*P value reported for Welch ANOVA test due to inhomogeneity of variances between groups.

BMI, Body Mass Index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; GOLD, The Global Initiative for Chronic Obstructive Lung Disease; SBP, systolic blood pressure.